Cell Invasion and Migration Assay Market by Type of Assay (Cell Invasion Assay and Cell Migration Assay), Application Areas (Drug Discovery, Screening and Tumor Study), Detection Method Used (Colorimetry and Fluorometry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2022 – 2035

  • Lowest Price Guaranteed From USD 5,899

  • Published
    May 2022

  • Pages
    189

  • View Count
    1404

Example Insights

Cell-Invasion-and-Migration-Assays-Market-Context-thumb Cell-Invasion-and-Migration-Assays-Market-List-of-Cell-Invasion-thumb Cell-Invasion-and-Migration-Assays-Market-Distribution-by-Storage-Temperature-thumb
Cell-Invasion-and-Migration-Assays-Market-Competitiveness-Analysis-thumb Cell-Invasion-and-Migration-Assays-Market-Grant-Analysis-thumb Cell-Invasion-and-Migration-Assays-Market-Publication-Analysis-thumb
Cell-Invasion-and-Migration-Assays-Market-Patent-Analysis-thumb Cell-Invasion-and-Migration-Assays-Market-Key-Parameters-thumb Cell-Invasion-and-Migration-Assays-Market-Distribution-by-Region-thumb

Overview

According to the World Health Organization (WHO), cancer is the second leading causes of mortality worldwide. In this context, it is important to highlight that around 10 million cancer deaths are reported globally each year. Further, it is estimated that, by 2030, around 21.4 million new patients are likely to be diagnosed with cancer annually. In fact, the global cancer burden is likely to increase by 70%, over the next two decades. With an aim to counter the rising number of cancer cases across the globe, several pharmaceutical players have developed cell invasion and migration assays to expediate the diagnosis process. It is worth highlighting that early diagnosis of cancer helps the patients to respond to therapy in an effective manner, thereby, increasing the chances of survival. Considering the various advantages offered by these cell-based assays, researchers across the globe have undertaken several initiatives to use these platforms for the diagnosis of a myriad of disease indications. The advancements in various technologies have propelled life science companies to use these assays in the drug discovery process, to enable the identification of potential lead candidates.

Given their extensive utilization in various drug discovery, tumor study and screening applications, there has been a significant rise in the revenue generation potential associated with cell invasion and migration assay kits. The current market landscape is consolidated and primarily dominated by the presence of large players. It is also worth mentioning that over 900 patents related to the implementation of invasion and migration assays have been filed / granted in the past few years, demonstrating the continued innovation in this domain. Taking into consideration both historical and recent developments, it is evident that the cell invasion and migration assay kits market is anticipated to grow at a significant pace in the coming years.

Scope of the Report

The “Cell Invasion and Migration Assay Market by Type of Assay (Cell Invasion Assay and Cell Migration Assay), Application Areas (Drug Discovery, Screening and Tumor Study), Detection Method Used (Colorimetry and Fluorometry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2022 – 2035” report features an extensive study of the current market landscape and the likely future potential associated with the cell invasion and migration assay market, over the next decade. The study also includes a detailed analysis of key drivers and trends within this evolving market. Amongst other elements, the report features:

  • A detailed overview of the current market landscape of companies engaged in offering cell invasion and migration assays based on several parameters, such as year of establishment, company size, location of headquarters, type of end-user (industry and non-industry). 
  • A detailed overview of the overall market landscape of cell invasion and migration assays, based on several relevant parameters, such as type of cell culture (adherent and suspension cell culture), type of assay (cell invasion and cell migration assay),  number of  wells (24-well, 32-well, 48-well, 96-well and 384-well), pore size of wells (3 µm, 5 µm , 8 µm , 9 µm  and 12 µm), type of ECM coating (basement membrane extract,  collagen I, collagen IV,  fibronectin and laminin), storage temperature (ultra-low, frozen, refrigerated and room temperature), application area (drug discovery, screening  and tumor study), detection method used (colorimetry and fluorometry) and number of assays performed.
  • An insightful product competitiveness analysis of cell invasion and migration assays, based on their supplier strength (in terms of years of experience and company size) and product portfolio strength (which takes into account type of cell culture, number of wells, type of ECM coating, kit components, application area, detection method used and number of assays performed).
  • Elaborate profiles of cell-based assay providers (large and mid-sized companies, established before 2000). Each profile features a brief overview of the company, along with information on its product portfolio, recent developments and an informed future outlook.
  • A detailed review of around 675 peer-reviewed, scientific articles related to research on cell invasion and migration assays, based on several relevant parameters, such as year of publication, type of publication, popular keywords, top journals, top institutes and top authors (in terms of number of articles published).
  • An in-depth analysis of patents related to cell invasion and migration assays filed / granted since 2017, based on several relevant parameters, such as publication year, geographical location / patent jurisdiction, legal status, CPC symbols, emerging focus areas, type of applicant and leading players (in terms of number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents.
  • A detailed review of academic grants that have been awarded to various research institutes for projects focused on cell invasion and migration, during the period, 2017-2022, based on several parameters, such as year of grant award, amount awarded, support period, type of funding institute center, support period, grant application, purpose of grant award, grant activity code, NIH spending category, study section involved, popular NIH departments, recipient organization, regional distribution of recipient organization. Further, the chapter also highlights the popular recipient organizations, (in terms of number of grants and amount awarded) and prominent program officers.
  • A Bowman’s strategy clock framework to understand the pricing strategy of the cell invasion and migration assays offered by a company, along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the cell invasion and migration assays based upon its characteristics.

One of the key objectives of the report was to estimate the existing market size and estimate the future size of cell invasion and migration assays market. We have provided informed estimates on the evolution of the market, over the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of [A] type of assay (cell invasion assay and cell migration assay), [B] application area (drug discovery, screening and tumor study), [C] detection method used (colorimetry and fluorometry) and [D] key geographical regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our forecast model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered

  • Which companies are engaged in offering cell invasion and migration assays kits?
  • What is the most common assay format (in terms of number of wells) offered by cell invasion and migration assay providers? 
  • What are the key geographical regions where cell invasion and migration assay providers are located? 
  • What is the evolving trend of publications focused on cell invasion and migration assays?
  • Which companies are actively filing patents to drive innovation in the field of cell invasion and migration assays?
  • What are the key factors influencing the price of cell invasion and migration assays?
  • What are the key challenges associated with cell invasion and migration assays?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Contents

Chapter Outlines

Chapter 2 is an executive summary of key insights captured during our research. It offers a high-level view on the current state of cell invasion and migration assays market and its likely evolution in the short to mid-term and long-term.

Chapter 3 provides a general introduction to cell invasion and migration, including a discussion on the Boyden Chamber’s principle. It further highlights different types of cell invasion and migration assays, along with information on the key challenges associated with this domain. Furthermore, it provides information on the role of kit components in cell invasion and migration assays and their various applications. 

Chapter 4 provides a detailed assessment of the current market landscape of companies engaged in offering cell invasion and migration assays based on several parameters, such as year of establishment, company size, location of headquarters, type of end-user (industry and non-industry). It is worth highlighting that during our research, we were able to identify 83 cell invasion and migration assays that were assessed on various relevant parameters, such as type of cell culture (adherent cell culture and suspension cell culture), type of assay (cell invasion assay and cell migration assay), number of  wells (24-well, 32-well, 48-well, 96-well and 384-well), pore size of wells (3 µm, 5 µm , 8 µm , 9 µm  and 12 µm), type of ECM coating (basement membrane extract,  collagen I, collagen IV,  fibronectin and laminin,), storage temperature (ultra-low, frozen, refrigerated and room temperature), application area (drug discovery, screening  and tumor study), detection method used (colorimetry and fluorometry) and number of assays performed.

Chapter 5 provides an insightful product competitiveness analysis, highlighting the capabilities of cell invasion and migration assay kit providers, based on supplier strength (in terms of years of experience and company size) and product portfolio strength (taking into account type of cell culture, number of wells, type of ECM coating, kit components, application area, detection method used and number of assays performed).

Chapter 6 provides elaborate profiles of key players (large and mid-sized companies, established before 2000) offering cell-based assay products. Each profile features a brief overview of the company, along with information on its product portfolio, recent developments and an informed future outlook.

Chapter 7 provides a detailed review of around 675 peer-reviewed, scientific articles related to research on cell invasion and migration assays, based on several relevant parameters, such as year of publication, type of publication, and popular keywords, top journals, top institutes and top authors (in terms of number of articles published).

Chapter 8 presents an analysis of patents related to cell invasion and migration assays, filed / granted since 2017, based on several relevant parameters, such as publication year, geographical location / patent jurisdiction, legal status, CPC symbols, emerging focus areas, type of applicant and leading players (in terms of number of patents). In addition, it features a patent valuation analysis, which evaluates the qualitative and quantitative aspects of patents.

Chapter 9 presents an analysis on academic grants that have been awarded to various research institutes for projects focused on cell invasion and migration, during the period, 2017-2022, based on several relevant parameters, such as year of grant award, amount awarded, support period, type of funding institute center and support period, grant application, purpose of grant award, grant activity code, NIH spending category, study section involved, popular NIH departments, recipient organization, regional distribution of recipient organization. Further, the chapter also highlights the popular recipient organizations, (in terms of number of grants and amount awarded) and prominent program officers.

Chapter 10 presents a Bowman’s strategy clock framework to understand the pricing strategy of the cell invasion and migration assays offered by a company, along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the cell invasion and migration assays based upon its characteristics.

Chapter 11 presents an insightful market forecast analysis, highlighting the future potential of cell invasion and migration assays market till 2035. We have segmented the market on the basis of type of assay (cell invasion assay and cell migration assay), application area (drug discovery, screening and tumor study), detection method used (colorimetry and fluorometry) and key geographical regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World).

Chapter 12 is a summary of the entire report. It provides the key takeaways and presents our independent opinion of the cell invasion and migration assays market, based on the research and analysis described in the previous chapters.

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in the report.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY
2.1. Chapter Overview

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Cell Invasion and Migration Assays
3.2.1. Introduction to Boyden Chamber Principle

3.3. Classification of Cell Invasion / Migration Assays
3.3.1. Scratch Assay
3.3.2. Cell Exclusion Assay
3.3.3. Spheroid Migration Assay
3.3.4. Microcarrier Bead Assay
3.3.5. Capillary Chamber Migration Assay
3.3.6. Trans-well Invasion Assay
3.3.7. Gelatin degradation assay
3.3.8. Spheroid Invasion Assay

3.4. Role of Kit Components in Cell Invasion / Migration Assays
3.5. Applications of Cell Invasion / Migration Assays
3.5.1. Screening and Detection
3.5.2. Drug Discovery
3.5.3. Cancer Research
3.6. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Cell Invasion and Migration Assays: List of Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Type of End-User
4.3. Cell Invasion and Migration Assays: Market Landscape
4.3.1. Analysis by Type of Cell Culture
4.3.2. Analysis by Type of Assay
4.3.3. Analysis by Number of Wells
4.3.4. Analysis by Pore Size of Wells
4.3.5. Analysis by Type of ECM Coating
4.3.6. Analysis by Storage Temperature
4.3.7. Analysis by Application Area
4.3.8. Analysis by Detection Method Used
4.3.9. Analysis by Number of Assays Performed
4.3.10. Analysis by Type of Assay and Detection Method Used
4.3.11. Analysis of Assay Providers by Type of Assay and Application Area (Grid Representation)
4.3.12. Analysis of Assays by Type of Assay, Number of Assays Performed and Number of Wells (Heat Map Representation)

5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis
5.4.1. Cell Invasion Assays Offered by Small Companies
5.4.2. Cell Invasion Assays Offered by Mid-sized Companies
5.4.3. Cell Invasion Assays Offered by Large Companies
5.4.4. Cell Invasion Assays Offered by Very Large Companies
5.5. Product Competitiveness Analysis
5.5.1. Cell Migration Assays Offered by Small Companies
5.5.2. Cell Migration Assays Offered by Mid-sized Companies
5.5.3. Cell Migration Assays Offered by Large Companies
5.5.4. Cell Migration Assays Offered by Very Large Companies

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Abcam
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. BioVision
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. Enzo Life Sciences
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook

6.5. MilliporeSigma
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. R&D Systems
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. Sigma-Aldrich
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook

7. PUBLICATION ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Cell Invasion and Migration Assays: List of Publications
7.3.1. Analysis by Quarterly Trend of Publications (2021-2022)
7.3.2. Analysis by Type of Publication
7.3.3. Most Popular Journals: Analysis by Number of Publications
7.3.4. Most Popular Publisher: Analysis by Number of Publications
7.3.5. Most Popular Copyright Holder: Analysis by Number of Publications
7.3.6. Publication Analysis: Most Popular Keywords
7.3.7. Analysis by Affiliated Institutes
7.3.8. Geographical Analysis of Affiliated Institutes
7.3.9. Analysis by Funding Institutes

8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Cell Invasion and Migration Assays: Patent Analysis
8.3.1. Analysis by Type of Patent
8.3.2. Analysis by Patent Publication Year
8.3.3 Year-wise Trend by Number of Granted Patent and Patent Applications
8.3.4. Analysis by Issuing Authority
8.3.5. Analysis by Patent Age
8.3.6. Analysis by CPC Symbols
8.3.7. Leading Players: Analysis by Number of Patents

8.4 Cell Invasion and Migration Assays: Patent Benchmarking Analysis
8.4.1. Analysis by Patent Characteristics
8.4.2 Analysis by Geography
8.5. Cell Invasion and Migration Assays: Patent Valuation Analysis

9. GRANT ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Cell Invasion and Migrations Assays: Grant Analysis
9.3.1. Analysis by Year of Grant Award
9.3.2. Analysis by Amount Awarded
9.3.3. Analysis by Support Period
9.3.4. Analysis by Funding Institute Center and Support Period
9.3.5. Analysis by Type of Grant Application
9.3.6. Analysis by Purpose of Grant Award
9.3.7. Analysis By Activity Code
9.3.8. Analysis by NIH Spending Category (Word Cloud Representation)
9.3.9. Analysis by Study Section Involved
9.3.10. Popular NIH Departments: Analysis by Number of Grants
9.3.11. Analysis by Type of Recipient Organization
9.3.12. Prominent Program Officers: Analysis by Number of Grants
9.3.13. Popular Recipient Organizations: Analysis by Number of Grants
9.3.14. Popular Recipient Organizations: Analysis by Grant Amount
9.3.15. Analysis by Region of Recipient Organization

10. BOWMAN CLOCK PRICING STRATEGY
10.1. Chapter Overview
10.2. Bowman Strategy Clock
10.2.1. Two Dimensions of Bowman Strategy Clock
10.2.2. Eight Positions on Bowman Strategy Clock

10.3. Roots Analysis Framework
10.3.1. Methodology
10.3.2. Theoretical Framework and Price Evaluation Hypothesis
10.3.3. Results and Interpretation
10.3.3.1. Product Price Evaluation Matrix: Information on Type of Assay
10.3.3.2. Product Price Evaluation Matrix: Information on Number of Wells
10.3.3.3. Product Price Evaluation Matrix: Information on Pore Size of Wells
10.3.3.4. Product Price Evaluation Matrix: Information on Type of ECM Coating
10.3.3.5. Product Price Evaluation Matrix: Information on Storage Temperature
10.3.3.6. Product Price Evaluation Matrix: Information on Application Area
10.3.3.7. Product Price Evaluation Matrix: Information on Detection Method Used
10.3.3.8. Product Price Evaluation Matrix: Information on Number of Assays Performed

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Global Cell Invasion and Migration Assays Market, 2022-2035

11.4 Cell Invasion and Migration Assays Market: Analysis by Type of Assay
11.4.1. Cell Invasion Assays Market, 2022-2035
11.4.2. Cell Migration Assays Market, 2022-2035

11.5. Cell Invasion and Migration Assays Market: Analysis by Application Area
11.5.1. Cell Invasion and Migration Assays Market for Drug Discovery, 2022-2035
11.5.2. Cell Invasion and Migration Assays Market for Screening, 2022-2035
11.5.3. Cell Invasion and Migration Assays Market for Tumor Study, 2022-2035

11.6. Cell Invasion and Migration Assays Market: Analysis by Detection Method Used
11.6.1. Cell Invasion and Migration Assays Market for Colorimetry, 2022-2035
11.6.2. Cell Invasion and Migration Assays Market for Fluorometry, 2022-2035

11.7. Cell Invasion and Migration Assays Market: Analysis by Geography
11.7.1. Cell Invasion and Migration Assays Market in North America, 2022-2035
11.7.2. Cell Invasion and Migration Assays Market in Europe, 2022-2035
11.7.3. Cell Invasion and Migration Assays Market in Asia-Pacific, 2022-2035
11.7.4. Cell Invasion and Migration Assays Market in Latin America, 2022-2035
11.7.5. Cell Invasion and Migration Assays Market in Middle East and North Africa, 2022-2035
11.7.6. Cell Invasion and Migration Assays Market in Rest of the World, 2022-2035

12. CONCLUSION
12.1. Chapter Overview

13. APPENDIX I: TABULATED DATA

14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Publication Analysis
Figure 2.3 Executive Summary: Patent Analysis
Figure 2.4 Executive Summary: Grant Analysis
Figure 2.5 Executive Summary: Bowman Clock Pricing Strategy
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Mechanism of Cell Migration Assay
Figure 3.2 Mechanism of Cell Invasion Assay
Figure 4.1 Cell Invasion and Migration Assay Providers: Distribution by Year of Establishment
Figure 4.2 Cell Invasion and Migration Assay Providers: Distribution by Company Size
Figure 4.3 Cell Invasion and Migration Assay Providers: Distribution by Location of Headquarters
Figure 4.4 Cell Invasion and Migration Assay Providers: Distribution by Type of End-User
Figure 4.5 Cell Invasion and Migration Assays: Distribution by Type of Cell Culture
Figure 4.6 Cell Invasion and Migration Assays: Distribution by Type of Assay
Figure 4.7 Cell Invasion and Migration Assays: Distribution by Number of Wells
Figure 4.8 Cell Invasion and Migration Assays: Distribution by Pore Size of Wells
Figure 4.9 Cell Invasion and Migration Assays: Distribution by Type of ECM Coating
Figure 4.10 Cell Invasion and Migration Assays: Distribution by Storage Temperature
Figure 4.11 Cell Invasion and Migration Assays: Distribution by Application Area
Figure 4.12 Cell Invasion and Migration Assays: Distribution by Detection Method Used
Figure 4.13 Cell Invasion and Migration Assays: Distribution by Number of Assays Performed
Figure 4.14 Cell Invasion and Migration Assays: Distribution by Type of Assay and Detection Method Used
Figure 4.15 Cell Invasion and Migration Assay Providers: Distribution by Type of Assay and Application Area (Grid Representation)
Figure 4.16 Cell Invasion and Migration Assays: Distribution of Assays by Type of Assay, Number of Assays Performed and Number of Wells (Heat Map Representation)
Figure 5.1 Product Competitiveness Analysis: Distribution of Cell Invasion Assays Offered by Small Companies (Peer Group 1)
Figure 5.2 Product Competitiveness Analysis: Distribution of Cell Invasion Assays Offered by Mid-sized Companies (Peer Group 2)
Figure 5.3 Product Competitiveness Analysis: Distribution of Cell Invasion Assays Offered by Large Companies (Peer Group 3)
Figure 5.4 Product Competitiveness Analysis: Distribution of Cell Invasion Assays Offered by Very Large Companies (Peer Group 4)
Figure 5.5 Product Competitiveness Analysis: Distribution of Cell Migration Assays Offered by Small Companies (Peer Group 1)
Figure 5.6 Product Competitiveness Analysis: Distribution of Cell Migration Assays Offered by Mid-sized Companies (Peer Group 2)
Figure 5.7 Product Competitiveness Analysis: Distribution of Cell Migration Assays Offered by Large Companies (Peer Group 3)
Figure 5.8 Product Competitiveness Analysis: Distribution of Cell Migration Assays Offered by Very Large Companies (Peer Group 4)
Figure 7.1 Publication Analysis: Quarterly Distribution of Publications, 2021-2022
Figure 7.2 Publication Analysis: Distribution by Type of Publication
Figure 7.3 Most Popular Journals: Distribution by Number of Publications
Figure 7.4 Most Popular Publishers: Distribution by Number of Publications
Figure 7.5 Most Popular Copyright Holders: Distribution by Number of Publications
Figure 7.6 Publication Analysis: Most Popular Keywords
Figure 7.7 Publication Analysis: Distribution by Affiliated Institutes
Figure 7.8 Publication Analysis: Geographical Distribution of Affiliated Institutes
Figure 7.9 Publication Analysis: Distribution by Funding Institutes
Figure 8.1 Patent Analysis: Distribution by Type of Patent
Figure 8.2 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2017-2022
Figure 8.3 Patent Analysis: Year-wise Trend by Number of Granted Patent and Patent Applications, 2017-2022
Figure 8.4 Patent Analysis: Distribution by Issuing Authority
Figure 8.5 Patent Analysis: Distribution by Patent Age
Figure 8.6 Patent Analysis: Distribution by CPC Symbols
Figure 8.7 Leading Industry Players: Distribution by Number of Patents
Figure 8.8 Leading Non-Industry Players: Distribution by Number of Patents
Figure 8.9 Patent Benchmarking Analysis: Distribution of Leading Industry Players by Patent Characteristics (CPC Symbols)
Figure 8.10 Patent Benchmarking Analysis: Distribution of Leading Industry Players by International Patents
Figure 8.11 Cell Invasion and Migration Assays: Patent Valuation
Figure 9.1 Grant Analysis: Cumulative Trend by Year of Grant Award, 2017-2022
Figure 9.2 Grant Analysis: Distribution by Amount Awarded (USD Million), 2017-2022
Figure 9.3 Grant Analysis: Distribution by Support Period
Figure 9.4 Grant Analysis: Distribution by Funding Institute Center and Support Period
Figure 9.5 Grant Analysis: Distribution by Type of Grant Application
Figure 9.6 Grant Analysis: Distribution by Purpose of Grant Award
Figure 9.7 Grant Analysis: Distribution by Activity Code
Figure 9.8 Word Cloud: NIH Spending Category
Figure 9.9 Grant Analysis: Distribution by Study Section Involved
Figure 9.10 Popular NIH Departments: Distribution by Number of Grants
Figure 9.11 Grant Analysis: Distribution by Type of Recipient Organization
Figure 9.12 Prominent Program Officers: Distribution by Number of Grants
Figure 9.13 Popular Recipient Organizations: Distribution by Number of Grants
Figure 9.14 Popular Recipient Organization: Distribution by Grant Amount
Figure 9.15 Grant Analysis: Distribution by Region of Recipient Organization
Figure 10.1 Cell Invasion and Migration Assays: Bowman Clock Pricing Strategy Matrix
Figure 10.2 Cell Invasion and Migration Assays: Bowman Clock Pricing Strategy Graphical Interpretation
Figure 11.1 Global Cell Invasion and Migration Assays Market, 2022-2035 (USD Million)
Figure 11.2 Cell Invasion and Migration Assays Market: Distribution by Type of Assay
Figure 11.3 Cell Invasion Assays Market, 2022-2035 (USD Million)
Figure 11.4 Cell Migration Assays Market, 2022-2035 (USD Million)
Figure 11.5 Cell Invasion and Migration Assays Market: Distribution by Application Area
Figure 11.6 Cell Invasion and Migration Assays Market for Drug Discovery, 2022-2035 (USD Million)
Figure 11.7 Cell Invasion and Migration Assays Market for Screening, 2022-2035 (USD Million)
Figure 11.8 Cell Invasion and Migration Assays Market for Tumor Study, 2022-2035 (USD Million)
Figure 11.9 Cell Invasion and Migration Assays Market: Distribution by Detection Method Used
Figure 11.10 Cell Invasion and Migration Assays Market for Colorimetry, 2022-2035 (USD Million)
Figure 11.11 Cell Invasion and Migration Assays Market for Fluorometry, 2022-2035 (USD Million)
Figure 11.12 Cell Invasion and Migration Assays Market: Distribution by Geography
Figure 11.13 Cell Invasion and Migration Assays Market in North America, 2022-2035 (USD Million)
Figure 11.14 Cell Invasion and Migration Assays Market in Europe, 2022-2035 (USD Million)
Figure 11.15 Cell Invasion and Migration Assays Market in Asia-Pacific, 2022-2035 (USD Million)
Figure 11.16 Cell Invasion and Migration Assays Market in Latin America, 2022-2035 (USD Million)
Figure 11.17 Cell Invasion and Migration Assays Market in Middle East and North Africa, 2022-2035 (USD Million)
Figure 11.18 Cell Invasion and Migration Assays Market in Rest of the World, 2022-2035 (USD Million)
Figure 12.1 Concluding Remarks: Overall Market Landscape
Figure 12.2 Concluding Remarks: Publication Analysis
Figure 12.3 Concluding Remarks: Patent Analysis
Figure 12.4 Concluding Remarks: Grant Analysis
Figure 12.5 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 3.1 Role of Kit Components in Cell Invasion / Migration Assays
Table 4.1 Cell Invasion and Migration Assays: List of Providers
Table 4.2 Cell Invasion and Migration Assays: Information on Type of Cell Culture
Table 4.3 Cell Invasion and Migration Assays: Information on Type of Assay
Table 4.4 Cell Invasion and Migration Assays: Information on Number of Wells
Table 4.5 Cell Invasion and Migration Assays: Information on Pore Size of Wells
Table 4.6 Cell Invasion and Migration Assays: Information on Type of ECM Coating
Table 4.7 Cell Invasion and Migration Assays: Information on Storage Temperature
Table 4.8 Cell Invasion and Migration Assays: Information on Application Area
Table 4.9 Cell Invasion and Migration Assays: Information on Detection Method Used
Table 4.10 Cell Invasion and Migration Assays: Information on Number of Assays Performed
Table 6.1 Abcam: Key Highlights
Table 6.2 Abcam: Product Portfolio
Table 6.3 Abcam: Recent Developments and Future Outlook
Table 6.4 BioVision: Key Highlights
Table 6.5 BioVision: Product Portfolio
Table 6.6 Enzo Life Sciences: Key Highlight
Table 6.7 Enzo Life Sciences: Product Portfolio
Table 6.8 MilliporeSigma: Key Highlights
Table 6.9 MilliporeSigma: Product Portfolio
Table 6.10 R&D Systems: Key Highlights
Table 6.11 R&D Systems: Product Portfolio
Table 6.12 Sigma-Aldrich: Key Highlights
Table 6.13 Sigma-Aldrich: Product Portfolio
Table 7.1 Cell Invasion and Migration Assays: List of Publications
Table 8.1 Patent Analysis: CPC Symbols
Table 8.2 Patent Analysis: Most Popular CPC Symbols
Table 8.3 Patent Analysis: List of Top CPC Symbols
Table 8.4 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 8.5 Patent Analysis: List of Relatively Higher Value Patents
Table 10.1 Product Price Evaluation Matrix: Information on Type of Assay (USD)
Table 10.2 Product Price Evaluation Matrix: Information on Number of Wells (USD)
Table 10.3 Product Price Evaluation Matrix: Information on Pore Size of Wells (USD)
Table 10.4 Product Price Evaluation Matrix: Information on Type of ECM Coating (USD)
Table 10.5 Product Price Evaluation Matrix: Information on Storage Temperature (USD)
Table 10.6 Product Price Evaluation Matrix: Information on Application Area (USD)
Table 10.7 Product Price Evaluation Matrix: Information on Detection Method Used (USD)
Table 10.8 Product Price Evaluation Matrix: Information on Number of Assays Performed (USD)
Table 14.1 Cell Invasion and Migration Assay Providers: Distribution by Year of Establishment
Table 14.2 Cell Invasion and Migration Assay Providers: Distribution by Company Size
Table 14.3 Cell Invasion and Migration Assay Providers: Distribution by Location of Headquarters
Table 14.4 Cell Invasion and Migration Assay Providers: Distribution by Type of End-User
Table 14.5 Cell Invasion and Migration Assays: Distribution by Type of Cell Culture
Table 14.6 Cell Invasion and Migration Assays: Distribution by Type of Assay
Table 14.7 Cell Invasion and Migration Assays: Distribution by Number of Wells
Table 14.8 Cell Invasion and Migration Assays: Distribution by Pore Size of Wells
Table 14.9 Cell Invasion and Migration Assays: Distribution by Type of ECM Coating
Table 14.10 Cell Invasion and Migration Assays: Distribution by Storage Temperature
Table 14.11 Cell Invasion and Migration Assays: Distribution by Application Area
Table 14.12 Cell Invasion and Migration Assays: Distribution by Detection Method Used
Table 14.13 Cell Invasion and Migration Assays: Distribution by Number of Assays Performed
Table 14.14 Cell Invasion and Migration Assays: Distribution by Type of Assay and Detection Method Used
Table 14.15 Publication Analysis: Quarterly Distribution of Publications, 2021-2022
Table 14.16 Publication Analysis: Distribution by Type of Publication
Table 14.17 Most Popular Journals: Distribution by Number of Publications
Table 14.18 Most Popular Publishers: Distribution by Number of Publications
Table 14.19 Most Popular Copyright Holders: Distribution by Number of Publications
Table 14.20 Publication Analysis: Most Popular Keywords
Table 14.21 Publication Analysis: Distribution by Affiliated Institutes
Table 14.22 Publication Analysis: Geographical Distribution of Affiliated Institutes
Table 14.23 Publication Analysis: Distribution by Funding Institutes
Table 14.24 Patent Analysis: Distribution by Type of Patent
Table 14.25 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2017-2022
Table 14.26 Patent Analysis: Year-wise Trend by Number of Granted Patent and Patent Applications, 2017-2022
Table 14.27 Patent Analysis: Distribution by Issuing Authority
Table 14.28 Patent Analysis: Distribution by Patent Age
Table 14.29 Leading Industry Players: Distribution by Number of Patents
Table 14.30 Leading Non-Industry Players: Distribution by Number of Patents
Table 14.31 Patent Benchmarking Analysis: Distribution of Leading Industry Players by International Patents
Table 14.32 Cell Invasion and Migration Assays: Patent Valuation
Table 14.33 Grant Analysis: Cumulative Trend by Year of Grant Award, 2017-2022
Table 14.34 Grant Analysis: Distribution by Grant Amount Awarded (USD Million), 2017-2022
Table 14.35 Grant Analysis: Distribution by Support Period
Table 14.36 Grant Analysis: Distribution by Type of Grant Application
Table 14.37 Grant Analysis: Distribution by Purpose of Grant Award
Table 14.38 Grant Analysis: Distribution by Activity Code
Table 14.39 Grant Analysis: Distribution by Study Section Involved
Table 14.40 Popular NIH Departments: Distribution by Number of Grants
Table 14.41 Grant Analysis: Distribution by Types of Recipient Organization
Table 14.42 Prominent Program Officers: Distribution by Number of Grants
Table 14.43 Popular Recipient Organization: Distribution by Number of Grants
Table 14.44 Popular Recipient Organization: Distribution by Grant Amount
Table 14.45 Global Cell Invasion and Migration Assays Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.46 Cell Invasion and Migration Assays Market: Distribution by Type of Assay
Table 14.47 Cell Invasion Assays Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.48 Cell Migration Assays Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.49 Cell Invasion and Migration Assays Market: Distribution by Application Area
Table 14.50 Cell Invasion and Migration Assays Market for Drug Discovery, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.51 Cell Invasion and Migration Assays Market for Screening, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.52 Cell Invasion and Migration Assays Market for Tumor Study, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.53 Cell Invasion and Migration Assays Market: Distribution by Detection Method Used
Table 14.54 Cell Invasion and Migration Assays Market for Colorimetry, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.55 Cell Invasion and Migration Assays Market for Fluorometry, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.56 Cell Invasion and Migration Assays Market: Distribution by Geography
Table 14.57 Cell Invasion and Migration Assays Market in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.58 Cell Invasion and Migration Assays Market in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.59 Cell Invasion and Migration Assays Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.60 Cell Invasion and Migration Assays Market in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.61 Cell Invasion and Migration Assays Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)
Table 14.62 Cell Invasion and Migration Assays Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. Abcam
  2. Acomhal Research
  3. Alabama State University
  4. Albert Einstein College of Medicine
  5. Assay Genie
  6. Baltimore VA Medical Center
  7. Baylor College of Medicine
  8. Beckman Research Institute
  9. BioVision
  10. Boston University
  11. Brigham and Women's Hospital
  12. Brown University
  13. California Institute of Technology
  14. California State Polytechnic University
  15. Carnegie Mellon University
  16. Case Western Reserve University
  17. Cedars-Sinai Medical Center
  18. Cell Biolabs
  19. Cell Reprogramming & Therapeutics
  20. Cincinnati Children's Hospital Medical Center
  21. Cleveland Clinic Lerner College of Medicine
  22. Columbia University Health Sciences
  23. Cornell University
  24. Dana-Farber Cancer Institute
  25. Drexel University
  26. Duke University
  27. Echelon Biosciences
  28. Emory University
  29. Endomet Biosciences
  30. Enzo Life Sciences
  31. Fesarius Therapeutics
  32. Florida International University
  33. Florida State University
  34. Fox Chase Cancer Center
  35. Fred Hutchinson Cancer Research Center
  36. Georgetown University
  37. H. Lee Moffitt Cancer Center & Research Institute
  38. Icahn School of Medicine
  39. Indiana University–Purdue University Indianapolis
  40. Iowa State University
  41. Johns Hopkins University
  42. LifeSpan BioSciences
  43. Massachusetts General Hospital
  44. Massachusetts Institute of Technology
  45. Mayo Clinic
  46. Memorial Sloan Kettering Cancer Center
  47. MilliporeSigma
  48. Morehouse School of Medicine
  49. MyBioSource
  50. National Cancer Institute
  51. New Mexico State University
  52. New York University
  53. North Carolina Agricultural and Technical State University
  54. NYU Grossman School of Medicine
  55. Ohio State University
  56. Oregon Health & Science University
  57. Penn State Health Milton S. Hershey Medical Center
  58. Planet Biotechnology
  59. Platypus Technologies
  60. Ponce Health Sciences University
  61. R&D Systems 
  62. Ralph H. Johnson VA Medical Center
  63. Rockefeller University
  64. Roswell Park Comprehensive Cancer Center
  65. Rowan University
  66. Rutgers Biomedical and Health Sciences
  67. Salk Institute for Biological Studies
  68. Sanford Burnham Prebys
  69. Sapphire Biotech
  70. Sigma-Aldrich 
  71. St. Joseph's Hospital and Medical Center
  72. Stanford University
  73. Stony Brook University
  74. Stowers Institute for Medical Research
  75. Syntrix Biosystems
  76. Temple University 
  77. Texas A&M University
  78. The Catholic University of America
  79. The University of Texas
  80. The University of Texas Health Science Center
  81. The University of Texas MD Anderson Cancer Center
  82. Tufts University
  83. Tuskegee University
  84. Universidad Central Del Caribe
  85. University of Alabama
  86. University of Arizona
  87. University of Arkansas
  88. University of California
  89. University of Chicago
  90. University of Colorado Denver
  91. University of Connecticut
  92. University of Delaware
  93. University of Florida
  94. University of Houston
  95. University of Illinois
  96. University of Kentucky
  97. University of Louisville
  98. University of Maryland
  99. University of Miami
  100. University of Michigan
  101. University of Minnesota
  102. University of Nevada
  103. University of North Carolina
  104. University of Oklahoma Health Sciences Center
  105. University of Pennsylvania
  106. University of Pittsburgh
  107. University of Puerto Rico 
  108. University of South Dakota
  109. University of Southern California
  110. University of Toledo
  111. University of Utah
  112. University of Vermont College of Agriculture and Life Sciences
  113. University of Virginia
  114. University of Washington
  115. University of Wisconsin-Madison
  116. Upstate Medical University
  117. Utah State University
  118. VA Eastern Colorado Health Care System
  119. Vanderbilt University
  120. Vanderbilt University Medical Center
  121. Veterans Health Administration
  122. Washington University
  123. Weill Medical College of Cornell University
  124. West Virginia University
  125. Whitehead Institute
  126. Wistar Institute
  127. Wright State University
  128. Yale University

PRICING DETAILS

USD 5,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com